Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
29
BALY Quote, Financials, Valuation and Earnings
Last price:
$10.03
Seasonality move
:
-3.01%
Day range:
$9.55 - $10.00
52-week range:
$8.46 - $23.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.20x
P/B ratio:
0.61x
Volume:
49.4K
Avg. volume:
141.8K
1-year change:
-28.12%
Market cap:
$488.7M
Revenue:
$2.5B
EPS (TTM):
-$11.70
Earnings Data
Next earnings date for BALY
Jul 31
2025
Most recent earnings per share
-$1.75
Missed by $1.22
(Mar 5/2025)
Consensus Estimate
-$0.53
(Mar 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BALY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $665.6M | -- | -- | -$0.36 | -- |
| 07/31/2025 | Q2 | $651M | -- | -- | -$0.36 | -- |
| 05/12/2025 | Q1 | $594.5M | -- | -- | -$1.01 | -- |
| 03/05/2025 | Q4 | $597M | $580.4M | -$1.75 | -$0.53 | -$1.22 |
| 11/06/2024 | Q3 | $654.1M | $630M | -$5.10 | -- | -- |
| 06/30/2024 | Q2 | $641.2M | $621.7M | -$1.24 | -- | -- |
| 03/31/2024 | Q1 | $627.3M | $618.5M | -$3.61 | -- | -- |
| 12/31/2023 | Q4 | $623.1M | $611.7M | -$5.11 | -- | -- |
| 09/30/2023 | Q3 | $634.5M | $632.5M | -$1.15 | -- | -- |
| 06/30/2023 | Q2 | $608.6M | $606.2M | -$0.48 | -- | -- |
| 03/31/2023 | Q1 | -- | $598.7M | $3.24 | -- | -- |
| 12/31/2022 | Q4 | -- | $576.7M | -$8.87 | -- | -- |
| 09/30/2022 | Q3 | -- | $578.2M | $0.01 | -- | -- |
| 06/30/2022 | Q2 | -- | $552.5M | $0.98 | -- | -- |
| 03/31/2022 | Q1 | -- | $548.3M | $0.03 | -- | -- |
| 12/31/2021 | Q4 | -- | $547.7M | -$1.87 | -- | -- |
| 09/30/2021 | Q3 | -- | $314.8M | -$1.16 | -- | -- |
| 06/30/2021 | Q2 | -- | $267.7M | $1.40 | -- | -- |
| 03/31/2021 | Q1 | -- | $192.3M | -$0.30 | -- | -- |
| 12/31/2020 | Q4 | -- | $118.1M | $0.61 | -- | -- |
| 09/30/2020 | Q3 | -- | $116.6M | $0.22 | -- | -- |
| 06/30/2020 | Q2 | -- | $28.9M | -$0.77 | -- | -- |
| 03/31/2020 | Q1 | -- | $109.1M | -$0.28 | -- | -- |
| 12/31/2019 | Q4 | -- | $130.4M | $0.40 | -- | -- |
| 09/30/2019 | Q3 | -- | $129.3M | $0.18 | -- | -- |
| 06/30/2019 | Q2 | -- | $143.2M | $0.42 | -- | -- |
| 03/31/2019 | Q1 | -- | $120.6M | $0.46 | -- | -- |
| 12/31/2018 | Q4 | -- | $111.4M | $0.63 | -- | -- |
| 09/30/2018 | Q3 | -- | $110.5M | $0.45 | -- | -- |
| 06/30/2018 | Q2 | -- | $110.8M | $0.49 | -- | -- |
| 03/31/2018 | Q1 | -- | $104.8M | $0.29 | -- | -- |
Ballys Earnings Questions
-
How Much did Ballys Generate in Revenue Last Quarter?
Ballys reported $580.4M worth of top line sales in its most recent quarter.
-
Did Ballys Beat Earnings Last Quarter?
Ballys announced earnings per share of -$1.75 which represents a miss of analyst forecast a -$0.53 per share.
-
Is Ballys Profitable?
Ballys reported $312.6M that represents $6.42 per share over the last quarter.
-
What is the Analyst Consensus for Ballys EPS Next Year?
Ballys's earnings are forecast to decrease from -$11.71 per share to -$10.49 per share next year representing a decrease of -89.28%.
-
When is Ballys's Earnings Date?
Ballys's next earnings date is July 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
